Specific reactions of S-nitrosothiols with cysteine hydrolases: A comparative study between dimethylargininase-1 and CTP synthetase

Protein Science

Volumn 16, Issue 8, 2007, Pages 1522-1534

  Braun, Oliver ^a   Knipp, Markus ^a,b   Chesnov, Serge ^a   Vašák, Milan ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b University of Arizona   (United States)

Author keywords

CTP synthetase; Dimethylargininase; Glutamine amidotransferase; Hyperhomocyst(e)inemia; Nitric oxide; S nitrosothiols; S transnitrosation

Indexed keywords

CYTIDINE TRIPHOSPHATE SYNTHASE; DIMETHYLARGININASE 1; S NITROSOGLUTATHIONE; S NITROSOTHIOL; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; KINETICS; MOLECULAR MODEL; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN STABILITY;

AMIDOHYDROLASES; ANIMALS; BINDING SITES; CARBON-NITROGEN LIGASES; CATTLE; CYSTEINE; HOMOCYSTEINE; KINETICS; MODELS, MOLECULAR; S-NITROSOTHIOLS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 34547588238     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.062718507     Document Type: Article

References (70)

1. Aldrige, W.N. 1950. Some properties of specific cholinesterase with particular reference to the mechanism of inhibition by diethyl p-nitrophenyl thiophosphate (E 605) and analogues. Biochem. J. 46: 451-460.
2. Anderson, P.M. 1983. CTP synthetase from Escherichia coli: An improved purification procedure and characterization of hysteretic and enzyme concentration effects on kinetic properties. Biochemistry 22: 3285-3292.
3. 2+-induced activation of human PAD4. Nat. Struct. Mol. Biol. 11: 777-783.
4. Bauer, P.M., Buga, G.M., Fukuto, J.M., Pegg, A.E., and Ignarro, L.J. 2001. Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme. J. Biol. Chem. 276: 34458-34464.
5. Böger, R.H. 2001. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inemia in humans. Clin. Sci. 100: 161-167.
6. Böger, R.H., Bode-Böger, S.M., Sydow, K., Heistad, D.D., and Lentz, S.R. 2000. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 20: 1557-1564.
7. Böger, R.H., Vallance, P., and Cooke, J.P. 2003. Asymmetric dimethylarginine (ADMA): A key regulator of nitric oxide synthase. Atheroscler. Suppl. 4: 1-3.
8. Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu, N.S., et al. 1998. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54: 905-921.
9. Büdy, B., Sengupta, S., DiBello, P.M., Kinter, M.T., and Jacobsen, D.W. 2001. A facile synthesis of homocysteine-cysteine mixed disulfide. Anal. Biochem. 291: 303-305.
10. Chittur, S.V., Klem, T.J., Shafer, C.M., and Davisson, V.J. 2001. Mechanism for acivicin inactivation of triad glutamine amidotransferases. Biochemistry 40: 876-887.
11. Colasanti, M. and Suzuki, H. 2000. The dual personality of NO. Trends Pharmacol. Sci. 21: 249-252.
12. Copeland, R.A. 2000. Enzymes: A practical introduction to structure, mechanism, and data analysis, 2nd ed. John Wiley & Sons, Inc., New York.
13. Dairou, J., Atmane, N., Dupret, J.M., and Rodrigues-Lima, F. 2003. Reversible inhibition of the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 by S-nitrosothiols. Biochem. Biophys. Res. Commun. 307: 1059-1065.
14. Das, K., Butler, G.H., Kwiatkowski, V., Clark Jr., A.D., Yadav, P., and Arnold, E. 2004. Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism. Structure 12: 657-667.
15. Duerre, J.A. and Miller, C.H. 1966. Preparation of L-homocysteine from L-homocysteine thiolactone. Anal. Biochem. 17: 310-315.
16. Endrizzi, J.A., Kim, H.S., Anderson, P.M., and Baldwin, E.P. 2004. Crystal structure of Escherichia coli cytidine triphosphate synthetase, a nucleotide-regulated glutamine amidotransferase/ATP-dependent amidoligase fusion protein and homologue of anticancer and antiparasitic drug targets. Biochemistry 43: 6447-6463.
17. Feelisch, M. and Stamler, J.S. 1996. Donors of nitrogen oxides. In Methods in nitric oxide research. (eds. M. Feelisch and J.S. Stamler), pp. 71-115. John Wiley & Sons Ltd., Chichester, UK.
18. Frey, D., Braun, O., Briand, C., Vašák, M., and Grütter, M.G. 2006. Structure of the mammalian NOS regulator dimethylarginine dimethylaminohydrolase: A basis for the design of specific inhibitors. Structure 14: 901-911.
19. Gaston, B. 1999. Nitric oxide and thiol groups. Biochim. Biophys. Acta 1411: 323-333.
20. Goto, M., Omi, R., Nakagawa, N., Miyahara, I., and Hirotsu, K. 2004. Crystal structures of CTP synthetase reveal ATP, UTP, and glutamine binding sites. Structure 12: 1413-1423.
21. Grasetti, D.R. and Murray, J.F. 1967. Determination of sulfhydryl groups with 2,2′- or 4,4′-dithiopyridine. Arch. Biochem. Biophys. 119: 41-49.
22. Hao, G., Xie, L.J., and Gross, S.S. 2004. Argininosuccinate synthetase is reversibly inactivated by S-nitrosylation in vitro and in vivo. J. Biol. Chem. 279: 36192-36200.
23. Hess, D.T., Matsumoto, A., Kim, S.O., Marshall, H.E., and Stamler, J.S. 2005. Protein S-nitrosylation: Purview and parameters. Nat. Rev. Mol. Cell Biol. 6: 150-166.
24. Hillary, R.A. and Pegg, A.E. 2003. Decarboxylases involved in polyamine biosynthesis and their inactivation by nitric oxide. Biochim. Biophys. Acta 1647: 161-166.
25. Hogg, N. 2002. The biochemistry and physiology of S-nitrosothiols. Annu. Rev. Pharmacol. Toxicol. 42: 585-600.
26. Houk, K.N., Hietbrink, B.N., Bartberger, M.D., McCarren, P.R., Choi, B.Y., Voyksner, R.D., Stamler, J.S., and Toone, E.J. 2003. Nitroxyl disulfides, novel intermediates in transnitrosation reactions. J. Am. Chem. Soc. 125: 6972-6976.
27. Humm, A., Fritsche, E., Steinbacher, S., and Huber, R. 1997. Crystal structure and mechanism of human L-arginine:glycine amidinotransferase: A mitochondrial enzyme involved in creatine biosynthesis. EMBO J. 16: 3373-3385.
28. Kakoki, M., Kim, H.S., Edgell, C.J.S., Maeda, N., Smithies, O., and Mattson, D.L. 2006. Amino acids as modulators of endothelium-derived nitric oxide. Am. J. Physiol. Renal Physiol. 291: F297-F304.
29. Kitz, R. and Wilson, I.B. 1962. Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. J. Biol. Chem. 237: 3245-3249.
30. Knipp, M. 2006. How to control NO production in cells: Nω,Nω-Dimethyl-Larginine dimethylaminohydrolase as a novel drug target. ChemBioChem 7: 879-889.
31. Knipp, M. and Vašák, M. 2000. A colorimetric 96-well microtiter plate assay for the determination of enzymatically formed citrulline. Anal. Biochem. 286: 257-264.
32. Knipp, M., Charnock, J.M., Garner, C.D., and Vašák, M. 2001. Structural and functional characterization of the Zn(II)-site in dimethylargininase-1 (DDAH-1) from bovine brain- Zn(II) release activates DDAH-1. J. Biol. Chem. 276: 40449-40456.
33. Knipp, M., Braun, O., Gehrig, P.M., Sack, R., and Vašák, M. 2003. Zn(II)-free dimethylargininase-1 (DDAH-1) is inhibited upon specific Cys-S-nitrosylation. J. Biol. Chem. 278: 3410-3416.
34. Knipp, M., Braun, O., and Vašák, M. 2005. Searching for DDAH inhibitors: S-Nitroso-L-homocysteine is a chemical lead. J. Am. Chem. Soc. 127: 2372-2373.
35. Konorev, E.A., Kalyanaraman, B., and Hogg, N. 2000. Modification of creatine kinase by S-nitrosothiols: S-Nitrosation vs. S-thiolation. Free Radic. Biol. Med. 28: 1671-1678.
36. Leiper, J., Murray-Rust, J., McDonald, N., and Vallance, P. 2002. S-Nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: Further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc. Natl. Acad. Sci. 99: 13527-13532.
37. Lentz, S.R., Rodionov, R.N., and Dayal, S. 2003. Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: The potential role of ADMA. Atheroscler. Suppl. 4: 61-65.
38. Long, C.W. and Pardee, A.B. 1967. Cytidine triphosphate synthetase of Escherichia coli B.I. Purification and kinetics. J. Biol. Chem. 242: 4715-4721.
39. MacAllister, R.J., Parry, H., Kimoto, M., Ogawa, T., Russell, R.J., Hodson, H., Whitley, G.S.J., and Vallance, P. 1996. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br. J. Pharmacol. 119: 1533-1540.
40. Martínez-Ruiz, A. and Lamas, S. 2004. S-Nitrosylation: A potential new paradigm in signal transduction. Cardiovasc. Res. 62: 43-52.
41. Massière, F. and Badet-Denisot, M.-A. 1998. The mechanism of glutaminedependent amidotransferases. Cell. Mol. Life Sci. 54: 205-222.
42. Meininger, C.J. and Wu, G.Y. 1997. L-Glutamine inhibits nitric oxide synthesis in bovine venular endothelial cells. J. Pharmacol. Exp. Ther. 281: 448-453.
43. Meister, A. 1974. Glutathione, metabolism and function via the γ-glutamyl cycle. Life Sci. 15: 177-190.
44. Murray-Rust, J., Leiper, J., McAllister, M., Phelan, J., Tilley, S., Santa Maria, J., Vallance, P., and McDonald, N. 2001. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase. Nat. Struct. Biol. 8: 679-683.
45. G-dimethylarginine dimethylaminohydrolase, from rat kidney. J. Biol. Chem. 264: 10205-10209.
46. Padgett, C.M. and Whorton, A.R. 1995. S-Nitrosoglutathione reversibly inhibits GAPDH by S-nitrosylation. Am. J. Physiol. Cell Physiol. 38: C739-C749.
47. Pérez-Mato, I., Castro, C., Ruiz, F.A., Corrales, F.J., and Mato, J.M. 1999. Methionine adenosyltransferase S-nitrosylation is regulated by the basic and acidic amino acids surrounding the target thiol. J. Biol. Chem. 274: 17075-17079.
48. Perissinotti, L.L., Turjanski, A.G., Estrin, D.A., and Doctorovich, F. 2005. Transnitrosation of nitrosothiols: Characterization of an elusive intermediate. J. Am. Chem. Soc. 127: 486-487.
49. Rossiter, S., Smith, C.L., Malaki, M., Nandi, M., Gill, H., Leiper, J.M., Vallance, P., and Selwood, D.L. 2005. Selective substrate-based inhibitors of mammalian dimethylarginine dimethylaminohydrolase. J. Med. Chem. 48: 4670-4678.
50. Selley, M.L. 2004. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons. J. Neurosci. Res. 77: 90-93.
51. Shirai, H., Blundell, T.L., and Mizuguchi, K. 2001. A novel superfamily of enzymes that catalyze the modification of guanidino groups. Trends Biochem. Sci. 26: 465-468.
52. Singh, S.P., Wishnok, J.S., Keshive, M., Deen, W.M., and Tannenbaum, S.R. 1996. The chemistry of the S-nitrosoglutathione/glutathione system. Proc. Natl. Acad. Sci. 93: 14428-14433.
53. Srivastava, S., Dixit, B.L., Ramana, K.V., Chandra, A., Chandra, D., Zacarias, A., Petrash, J.M., Bhatnagar, A., and Srivastava, S.K. 2001. Structural and kinetic modifications of aldose reductase by S- nitrosothiols. Biochem. J. 358: 111-118.
54. Stanger, O., Herrmann, W., Pietrzik, K., Fowler, B., Geisel, J., Dierkes, J., and Weger, M. 2003. DACH-LIGA homocystein (German, Austrian and Swiss Homocysteine Society): Consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: Guidelines and recommendations. Clin. Chem. Lab. Med. 41: 1392-1403.
55. Stone, E.M., Schaller, T.H., Bianchi, H., Person, M.D., and Fast, W. 2005. Inactivation of two diverse enzymes in the amidinotransferase superfamily by 2-chloroacteamidine: Dimethylargininase and peptidyl deiminase. Biochemistry 44: 13744-13752.
56. Stone, E.M., Costello, A.L., Tierney, D.L., and Fast, W. 2006. Substrateassisted cysteine deprotonation in the mechanism of dimethylargininase (DDAH) from Pseudomonas aeruginosa. Biochemistry 45: 5618-5630.
57. Stühlinger, M.C., Tsao, P.S., Her, J.-H., Kimoto, M., Balint, R.F., and Cooke, J.P. 2001. Homocysteine impairs the nitric oxide synthase pathway - Role of asymmetric dimethylarginine. Circulation 104: 2569-2575.
58. Stühlinger, M.C., Oka, R.K., Graf, E.E., Schmolzer, I., Upson, B.M., Kapoor, O., Szuba, A., Malinow, M.R., Wascher, T.C., Pachinger, O., et al. 2003. Endothelial dysfunction induced by hyperhomocyst(e)-inemia: Role of asymmetric dimethylarginine. Circulation 108: 933-938.
59. Tipton, K.F. 1989. Mechanism-based inhibitors. In Design of enzyme inhibitors as drugs (eds. M. Sandler and J.H. Smith), pp. 70-93. Oxford University Press, New York.
60. Tsikas, D., Sandmann, J., Rossa, S., Gutzki, F.-M., and Frölich, J.C. 1999. Investigations of S-transnitrosylation reactions between low- and highmolecular-weight S-nitroso compounds and their thiols by high-performance liquid chromatography and gas chromatography-mass spectrometry. Anal. Biochem. 270: 231-241.
61. Vallance, P. and Leiper, J. 2002. Blocking NO synthesis: How, where and why? Nat. Rev. Drug Discov. 1: 939-950.
62. Vallance, P., Bush, H.D., Mok, B.J., Hurtado-Guerrero, R., Gill, H., Rossiter, S., Wilden, J.D., and Caddick, S. 2005. Inhibition of dimethylarginine dimethylaminohydrolase (DDAH) and arginine deiminase (ADI) by pentafluorophenyl (PFP) sulfonates. Chem. Commun. 44: 5563-5565.
63. Wang, P.G., Xian, M., Tang, X., Wu, X., Wen, Z., Cai, T., and Janczuk, A.J. 2002. Nitric oxide donors: Chemical activities and biological applications. Chem. Rev. 102: 1091-1134.
64. Wong, P.S., Hyun, J., Fukuto, J.M., Shirota, F.N., DeMaster, E.G., Shoeman, D.W., and Nagasawa, H.T. 1998. Reaction between S-nitrosothiols and thiols: Generation of nitroxyl (HNO) and subsequent chemistry. Biochemistry 37: 5362-5371.
65. Xian, M., Chen, X.C., Liu, Z.Y., Wang, K., and Wang, P.G. 2000a. Inhibition of papain by S-nitrosothiols - Formation of mixed disulfides. J. Biol. Chem. 275: 20467-20473.
66. Xian, M., Wang, K., Chen, X.C., Hou, Y.C., McGill, A., Chen, X., Zhou, B., Zhang, Z.Y., Cheng, J.P., andWang, P.G. 2000b. Inhibition of protein tyrosine phosphatases by low-molecular-weight S-nitrosothiols and S-nitrosylated human serum albumin. Biochem. Biophys. Res. Commun. 268: 310-314.
67. Xian, M., Wang, Q.M., Chen, X.C., Wang, K., and Wang, P.G. 2000c. S-Nitrosothiols as novel, reversible inhibitors of human rhinovirus 3C protease. Bioorg. Med. Chem. Lett. 10: 2097-2100.
68. Yoo, J.H. and Lee, S.C. 2001. Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 158: 425-430.
69. Zalkin, H. and Smith, J.L. 1998. Enzymes utilizing glutamine as an amide donor. Adv. Enzymol. Relat. Areas Mol. Biol. 72: 87-144.
70. Zhang, Y. and Hogg, N. 2004. Formation and stability of S-nitrosothiols in RAW 264.7 cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 287: L467-L474.